Address:
- Suite 1101 Wohl Hospital (office)
Clinical Interest: Myeloproliferative Neoplasms, Venous Thromboembolisms, Cancer Associated Thrombosis, Anticoagulation, Coagulopathies
Research Interest: Myeloproliferative neoplasms, venous thromboembolisms, coagulopathies
Research: My research focus is in the myeloproliferative neoplasms specifically the pathobiology of thrombosis, bleeding and cytopenias as well as elucidating clinical factors and biomarkers affecting allogeneic hematopoietic stem cell transplant outcomes.
Biosketch
Education
- 2019: MS, Clinical Science, University of Texas Medical Branch, Galveston, TX
- 2017: MD, University of Texas Medical Branch, Galveston, TX
- 2010: BS in Biochemistry, University of Oklahoma (cum laude), Norman, OK
Post-Graduate Training
- 2024: Hematology/ Oncology Fellowship, Memorial Sloan Kettering Cancer Center
- 2021: Internal Medicine Residency, The University of Texas Health Science Center at Houston, Houston, TX
Academic Positions & Employment
- 2024-present: Assistant Professor, Hematology, Division, Washington University School of Medicine, St Louis, MO
Board Certification
- 2021: American Board of Internal Medicine
Professional Societies
- 2022-present: Member, American Society of Hematology
Honors & Awards
- 2023: American Society of Hematology Minority Hematology Fellow Award
- 2023: AACR/ASCO Methods in Clinical Cancer Research Participant
- 2023: Mortimer J. Lacher Fellowship Award from the Lymphoma Foundation at Memorial Sloan Kettering Cancer Center
- 2023: Ferguson Nazareth Award Fellowship Award, Memorial Sloan Kettering Cancer Center
- 2023: Memorial Sloan Kettering Cancer Center, Ferguson Nazareth Fellowship Award
Selected Publications
- Gangat N*, Ajufo H*, Abdelmagid M, Karrar O, McCullough K, Badar T, Foran J, Palmer J, Alkhateeb H, Mangaonkar A, Kuykendall A, Rampal RK, Tefferi A. IDH1 /2 inhibitor monotherapy in blast‐phase. Br J Haematol 2023 Aug 3.doi: 10.1111/bjh.19027. Online
- Ajufo HO, Waksal JA, Mascarenhas JO, Rampal RK. Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges. Therapeutic Advances in Hematology. 2023;14:20406207231177280. doi:10.1177/20406207231177282
- Goswamy R, Ajufo H, Maiti A, Brown R, Juneja H, Apostolidou E. Refractory Hydroa Vacciniforme-Like Lymphoma: Biological Insights from Morphoproteomic Analysis. IJHOSCR. Published online July 24, 2022. doi:10.18502/ijhoscr.v16i3.10141
- Maiti A, Kantarjian HM, Popat V, Borthakur G, Garcia-Manero G, Konopleva MY, DiNardo CD, Verstovsek S, Andreeff M, Kadia TM, Ajufo HO, Goswamy RV, Blanco C, Velasquez M, Daver NG, Pemmaraju N, Pierce SR, Wierda WG, Kornblau SM, Ravandi F, et al. Clinical value of event-free survival in acute myeloid leukemia. Blood Advances. 2020;4(8):1690-1699. doi:10.1182/bloodadvances.2019001150
- Thomas LM, Harper AR, Miner WA, Ajufo HO, Branscum KM, Kao L, Sims PA. Structure of Escherichia coli AdhP (ethanol-inducible dehydrogenase) with bound NAD. Acta Crystallogr F Struct Biol Cryst Commun. 2013;69(7):730-732. doi:10.1107/S1744309113015170